Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Personalis, Inc.

Personalis, Inc. (PSNL) Stock Overview

Explore Personalis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PSNL●NASDAQ
HealthcareMedical - Diagnostics & Research
$18.38
$1.50(8.89%)
U.S. Market opens in 63h 25m

Personalis, Inc. (PSNL)

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-16.75
EPS (TTM)$-1.09
ROE-0.46%
Fundamental Analysis

AI Price Forecasts

1 Month$15.24
3 Months$13.68
1 Year Target$13.03

PSNL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Personalis, Inc. (NASDAQ: PSNL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Personalis, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PSNL on the NASDAQ shows an RSI of 76.73, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $13.03 for the NASDAQ listing.

Key metrics behind Personalis, Inc.'s NASDAQ-traded stock include a P/E ratio of -16.75 and a market capitalization of 2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PSNL on the NASDAQ.

Price Performance (NASDAQ: PSNL)

1-Day Change
8.89%
5-Day Change
30.26%
1-Month Change
36.76%
3-Month Change
122.79%
6-Month Change
121.98%
Year-to-Date (YTD) Change
130.90%
1-Year Change
294.42%
3-Year Change
938.42%
5-Year Change
-1.71%
All-Time (Max) Change
-35.49%

Contact Information

https://www.personalis.com
650 752 1300
6600 Dumbarton Circle, Fremont, CA, 94555

Company Facts

2,600 Employees
IPO DateJun 20, 2019
CountryUS
Actively Trading

Frequently Asked Questions